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Active-site variants of Streptomyces griseus protease B with
peptide-ligation activity
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Background: Peptide-ligating technologies facilitate a range of manipulations
for the study of protein structure and function that are not possible using
conventional genetic or mutagenic methods. To different extents, the currently
available enzymatic and nonenzymatic methodologies are synthetically
demanding, sequence-dependent and/or sensitive to denaturants. No single
coupling method is universally applicable. Accordingly, new strategies for
peptide ligation are sought. 
Results: Site-specific variants (Ser195→Gly, S195G, and Ser195→Ala,
S195A) of Streptomyces griseus protease B (SGPB) were generated that
efficiently catalyze peptide ligation (i.e., aminolysis of ester-, thioester- and
para-nitroanilide-activated peptides). The variants also showed reduced
hydrolytic activity relative to the wild-type enzyme. The ratio of aminolysis to
hydrolysis was greater for the S195A variant, which was also capable of
catalyzing ligation in concentrations of urea as high as 2 M.
Conclusions: Mutagenic substitution of the active-site serine residue of SGPB
by either glycine or alanine has created a unique class of peptide-ligating
catalysts that are useful for coupling relatively stable ester- and para-
nitroanilide-activated substrates. Ligation proceeds through an acyl–enzyme
intermediate involving His57. Serine to alanine mutations may provide a general
strategy for converting proteases with chymotrypsin-like protein folds into
peptide-coupling enzymes. 
Introduction
Gene synthesis and oligonucleotide-directed mutagenesis
techniques make possible virtually any variation to the
primary sequence of proteins [1,2]. These site-specific
changes in primary sequence have proved, in turn, to be
powerful methods for dissecting relationships between
protein structure and function. Notably, these methods
are also a means for making useful modifications to
protein activity [3,4]. Although powerful and useful, con-
ventional molecular biology techniques are restricted to
the use of the 20 amino acids dictated by the genetic code.
A far wider range of manipulations to protein structure and
activity is conceivable if non-natural amino acids are used
in protein engineering [5–8]. 
Solid-phase synthesis permits the routine incorporation of
non-natural amino acids into short peptides [9]. Such
methods are currently too costly and synthetically chal-
lenging to permit the routine synthesis of entire proteins
containing novel amino acids. Using a ligation strategy,
peptides produced chemically, recombinantly or by partial
proteolysis can be spliced together to create full-length
proteins. Hence, non-natural amino acids may be site-
specifically incorporated into semi-synthetic proteins [10]. 
Existing methods of peptide ligation have been used to
generate proteins with a wide variety of novel features,
including unnatural catalytic residues, nonpeptidic back-
bones, and unique conformational probes [11–15]. Several
enzymatic and nonenzymatic peptide-coupling strategies
are currently in use; virtually all are performed with
unprotected peptides and in aqueous phase. The forma-
tion of a peptide bond from free amines and carboxylic
acids is, however, thermodynamically unfavourable in
water. Substrate peptides are therefore chemically pre-
activated and reaction conditions designed to allow the
products of ligation to be ‘kinetically trapped’ [16]. 
Kent and co-workers [17] have described an elegant
nonenzymatic method for ligating peptides in aqueous
phase. Donor peptides, activated with carboxy-terminal
thioesters, are reacted with acceptor peptides that have
unblocked amino-terminal cysteine residues. Coupling
proceeds through a transient thioester intermediate
(between the cysteine thiol and the carbonyl carbon of the
activated peptide), which undergoes a spontaneous
intramolecular S→N acyl transfer to form a native peptide
bond. The development of methods to generate recombi-
nant proteins activated with carboxy-terminal thioesters
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has made this technology more accessible [18–23], and a
variety of proteins containing non-natural amino acids
have been generated [15,22,24]. Major disadvantages of
the technology are the relative lability of thioesters and
the sequence restrictions (X-Cys, X-Gly, Gly-X) at the
junction site [25].
The potential advantage of enzyme-catalyzed ligation
technology is that reactions can be performed using a
variety of activated leaving groups on the donor peptide
(i.e., not solely thioesters). Proteases (or protease vari-
ants) can ensure the regiospecific coupling of amino- and
carboxy-terminal ends of reacting peptides, and conse-
quently are less dependent on a particular leaving-group
chemistry. Furthermore, many proteases have been char-
acterized, covering a wide range of substrate specifici-
ties, thereby presenting the possibility of coupling
virtually any sequence of amino acids. Fundamental
objectives in developing protease-based methods for
peptide ligation are to find mutant enzymes that can
couple a broad range of sequences using activated pep-
tides that resist uncatalyzed hydrolysis. 
Through multiple mutations, Wells and co-workers
[14,26,27] converted the protease subtilisin BPN′ into the
peptide-ligating catalyst referred to as ‘subtiligase’. Subti-
ligase contains a catalytic serine to cysteine mutation
(S221C), which greatly reduces the amidase activity of the
enzyme, rendering it incapable of hydrolyzing the prod-
ucts of peptide-coupling reactions. Nevertheless, the
enzyme can be efficiently acylated by glycolate-ester-acti-
vated peptides. Attack on the resulting acyl–enzyme inter-
mediate is more facile for amine nucleophiles than for
water, and therefore aminolysis (ligation) is favored over
hydrolysis. Subtiligase variants with increased activities
and oxidative stabilities have also been selected using
phage display [28]. To date, subtiligase and its derivatives
are the only reported genetic enzyme variants active in
peptide coupling.
In the current study, mutants of a chymotrypsin-like
serine protease (Streptomyces griseus protease B, SGPB)
were investigated for their ability to couple peptides.
Enzymes of the chymotrypsin family of serine proteases
have a protein fold that is distinct from the subtilisin
family [29]. A diversity of chymotrypsin-like enzymes
have been described, including those with primary speci-
ficity for basic and acidic amino acids [29–31].
Results and discussion
Expression of SGPB variants
SGPB is a relatively small (18.6 kDa) monomeric, secreted
bacterial enzyme of the chymotrypsin clan of serine pro-
teases, containing a catalytic triad composed of His57,
Asp102 and Ser195 [29,32,33]. SGPB has primary speci-
ficity for peptide bonds following large hydrophobic
amino acids [34,35]. The protein contains two disulfide
bonds and is extremely stable, with activity in high con-
centrations of denaturants (6 M urea and 8 M guanidine
HCl (GnHCl)) and at high temperatures [36,37]. These
are potentially valuable properties in a peptide ligase, as
the semi-synthesis of proteins from relatively long pep-
tides is likely to involve denaturing conditions.
Two categories of mutation were investigated. Firstly,
the active-site serine residue of SGPB was mutated to
cysteine, in the expectation that an enzyme with subtili-
gase-like activity would be generated. Secondly, a cate-
gory of mutants was made in which the active-site serine
residue was replaced with either glycine or alanine. We
postulated that variant enzymes in the second category
would act as a platform for simultaneous binding of donor
and acceptor peptides, allowing the direct nucleophilic
attack of the acceptor amine on the carbonyl group of the
activated donor. Variants would contribute specificity
through substrate binding energy, and the negatively
charged transition state would be stabilized by the oxyan-
ion hole of SGPB [38].
In total, four genetic variants of SGPB were constructed:
Ser195 to cysteine (S195C), alanine (S195A), or glycine
(S195G), and a double mutant Ser195 to glycine/His57 to
asparagine (S195G/H57N). Variant genes were cloned in
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Figure 1
Production of SGPB variants from B. subtilis strain DB104. The
enzymes are produced as pre-pro-mature proteins. The pre- region
directs the protein to the cell surface for secretion, where it is cleaved
from the pro-mature region by signal peptidase. A ‘helper’ enzyme,
SGPD, which has the same specificity as SGPB, cleaves the mature
protein from the pro- region releasing it into the culture supernatant.
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the Escherichia coli/Bacillus subtilis shuttle vector pEB-11
and expressed in B. subtilis DB104 [31].
Wild-type SGPB is normally translated as a pre-pro-
mature enzyme. Subsequently, the zymogen is processed
at the pre-pro junction by a host-encoded signal peptidase
and processed at the pro-mature junction autocatalytically
[30,39]. As the mutants are poor amidases, a ‘helper’
enzyme was required to perform the pro-mature process-
ing (Figure 1). Streptomyces griseus protease D (SGPD) has
similar specificity to SGPB [30] and was therefore used to
perform the pro-mature processing event. Significantly,
SGPD differs from SGPB in terms of its size
(SGPD ≅ 36 kDa versus SGPB ≅ 18 kDa) and isoelectric
point (SGPB has a basic pI whereas SGPD has an acidic
pI) [30]. Mutants can, therefore, be readily separated from
the helper enzyme by ion-exchange chromatography.
S195A and S195G proteins were expressed and secreted
at ~1 mg/l by recombinant Bacillus; however, several
attempts to express protein from S195C and S195G/H57N
recombinants proved unsuccessful (Figure 2). Further
studies of these two variants were, therefore, not possible.
The S195A variant was produced in greater quantities
than the S195G variant, but at lower levels than the wild-
type enzyme. It is possible that the levels of variant
expression, and the absence of S195C and S195G/H57N
proteins, are related to nonproductive folding events. A
relationship between the folding and expression of SGPB
was observed previously [40]. The S195G and S195A vari-
ants were purified to homogeneity, and the serine to
glycine and serine to alanine mutations confirmed by
mass spectrometry.
Ligation and hydrolysis activity of SGPB variants
Purified SGPB variants were tested for their ability to cat-
alyze reactions between activated ‘donor’ peptides (i.e.,
peptides having carboxy-terminal ester, thioester or para-
nitroanilide (-pNA) groups) and nucleophilic ‘acceptor’ pep-
tides (i.e., peptides having a free amino-terminal amine). 
A time course for the S195A-catalyzed ligation of two pep-
tides is shown in Figure 3. The S195G variant was also
active in peptide ligation; however, it showed a lower
aminolysis to hydrolysis ratio compared with the S195A
mutant (Figure 4). Consequently, the S195G variant was
not further characterized in ligation reactions. Ligation
reactions show saturation kinetics (Figure 4) and do not
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Figure 2
Expression of SGPB variants. (a) Sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) and
(b) western blot of small-scale expression tests of the SGPB variants.
Lanes 1, pEB-11 (vector only); lanes 2, pEB-B8 (vector encoding wild-
type SGPB); lanes 3, pEB-HDa (vector encoding S195A); lanes 4,
pEB-HDg (vector encoding S195G); lanes 5, pEB-HDc (vector
encoding S195C); lanes 6, pEB-nDg (vector encoding
S195G/H57N); and lanes 7, purified SGPB.
Figure 3
Time course of the S195A-catalyzed ligation reaction, analyzed by
reversed phase high performance liquid chromatography (HPLC).
Peaks are assigned as follows: (a) 8 min (F-A-A-S-R-NH2,
nucleophile); (b) 14 min (N-succinyl-A-A-A-P-F-OH, hydrolysis
product); (c) 16.5 min (1,4-butanediol); (d) 19 min (N-succinyl-A-A-P-
F-F-A-A-S-R-NH2, ligated product); and (e) 23 min (N-succcinyl-A-A-
P-F-SBz, donor peptide).
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occur in the absence of enzyme. Notably, significant
uncatalyzed hydrolysis of thioester-activated donor pep-
tides took place during the ligation reaction, whereas
uncatalyzed hydrolysis of pNA-activated donors was not
observed — underscoring the advantage of working with
more stable donor peptides.
Kinetic studies indicate that both ligase variants have
reduced amidase activities compared with the wild-type
enzyme (Table 1), an anticipated consequence of the
replacement of Ser195. Interestingly, the serine to alanine
mutation in SGPB (S195A) reduced the hydrolytic activity
of the enzyme (kcat/Km) by a factor of 104, whereas the
analogous substitution in subtilisin (S221A) resulted in a
107-fold reduction [41].
A minimal kinetic scheme for reactions catalyzed by the
S195A variant is presented in Figure 5 and justified in the
discussion below. Significantly, the reaction kinetics are
consistent with a catalytic mechanism involving an
enzyme-bound intermediate.
Mechanism of ligation: evidence for an acyl-imidazole
intermediate
The hydrolysis reactions catalyzed by S195A (kcat/Km) differ
according to the leaving group of the donor peptides,
with thioesters (thiomethyl and thiobenzyl) reacting
more rapidly than esters, which react more rapidly than
para-nitroanilides. The product ratio (i.e., the ratio of
aminolysis to hydrolysis at a given acceptor concentration)
remains the same regardless of the donor peptide. These
two observations, as explained in detail by Fersht [42],
provide very strong evidence that the coupling reactions all
proceed via a common enzyme-bound intermediate [43]. 
Formation of an enzyme intermediate can be monitored by
the release of para-nitroaniline from a pNA-activated donor
peptide. Moreover, for reactions that involve an enzyme-
bound intermediate, the rate of pNA release should be
independent of the concentration of acceptor peptide. The
alternative possibility that an intermediate does not exist
requires that the coupling rate, as well as the rate of pNA
release, increase as acceptor concentration increases. 
The ratio of coupling to hydrolysis was observed to increase
with increasing acceptor concentration (see Figure 4), yet a
simultaneous decrease in the rate of pNA release was also
observed (Figure 6). As p-NA release and ligated product
formation clearly have different dependencies on nucle-
ophile concentration, a minimum of two steps are involved
in ligation. Consequently, the reaction mechanism involves
an enzyme-bound intermediate (Figure 5). The decrease in
the rate of pNA release at high acceptor concentrations was
fit to a competitive inhibition model (Figure 6), thereby
suggesting competition between donor and acceptor pep-
tides for the donor (P1)-binding site (Figure 5). 
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Figure 4
Ligation to hydrolysis ratios for the S195A- and S195G-catalyzed
ligation reactions as a function of nucleophile (NH2-F-A-A-S-R-NH2)
concentration. The standard ligation reactions were performed for
16 h, with varying amounts of the nucleophilic peptide. Data were fit to
a model of saturation kinetics.
Table 1
Kinetic constants for the hydrolysis of N-succinyl-A-A-P-F-pNA
by wild-type SGPB, S195G and S195A.
kcat (s–1) Km (M) kcat/Km (s–1M–1)
SGPB* 31.4 6.2 × 10–5 5.0 × 105
S195G† 1.1 × 10–3 3.0 × 10–4 3.7 × 100
S195A‡ 7.9 × 10–3 5.0 × 10–4 1.6 × 101
*From [47]. †Errors were estimated at 30%. ‡Errors were estimated
at 15%.
Figure 5
Mechanistic scheme for variant-catalyzed reactions. The leaving group
is indicated by X and is one of -pNA, -Sbz, -SMe or -OMe. 
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The pH profile of the S195A variant is consistent with the
enzyme-bound intermediate being an acylated imidazole
(Figure 7). At pH values below 6.5, the activity of the
enzyme, as measured by total product formation, falls off
dramatically. Histidine residues typically titrate in the
vicinity of pH 6.5 and protonation of the histidine’s imida-
zole ring eliminates the nucleophilicity of this group. Fur-
thermore, there are well-established precedents for
histidine’s role as a nucleophile [44,45]. For example,
Quinn et al. [44] proposed that para-nitrophenyl acetate
acylates the active-site histidine of α-lytic protease (a
homolog of SGPB) to generate an acyl-imidazole, and the
intermediate subsequently undergoes an N→O acyl trans-
fer to give the acylated serine.
Consistent with the formation of an acyl-imidazole inter-
mediate, both the hydrolysis and aminolysis activities of
the S195A variant were eliminated by the addition of the
irreversible serine protease inhibitor phenylmethylsul-
fonyl fluoride (PMSF) [46]. The enzyme was not irre-
versibly inactivated by PMSF as is the case for wild-type
SGPB, however. The S195A variant regained ~10% of its
activity over the course of a 24-hour incubation. Similar
results were obtained with the S195G variant. It is postu-
lated, therefore, that PMSF forms a covalent adduct with
the active-site histidine (His57), preventing reaction with
the donor peptide. Subsequently, the adduct slowly
hydrolyzes, regenerating an active ligase. Preliminary
attempts were made to isolate and directly characterize
the PMSF adduct using mass spectroscopy. Unfortu-
nately, because the intermediate is unstable, the attempts
proved unsuccessful.
Taken together, the results from the inhibitor, pH,
product ratio and kinetic studies indicate that the ligation
reaction proceeds through an acyl-enzyme intermediate
resulting from the nucleophilic attack on the activated
peptide by the imidazole of His57. The acyl-imidazole
intermediate is subsequently deacylated by either water
(hydrolysis) or the amine of the nucleophilic acceptor
peptide (ligation). 
Ligation efficiency
The efficiency of ligation to hydrolysis increases as the pH
of the solution increases (Figure 7). In addition, more
aminolysis is observed at higher acceptor concentrations
(Figure 4). These observations are consistent with the
aminolysis reaction requiring a neutral (deprotonated)
amine nucleophile, and ligation efficiency may therefore
be improved by working at higher pH and with greater
concentrations of acceptor peptide. 
Substrate specificity
To investigate the substrate specificity of the S195A
variant, the enzymatic hydrolysis of several substrate pep-
tides (N-succinyl-Ala–Ala–Pro–Xaa-pNA, where Xaa is the
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Figure 6
Rate of S195A-catalyzed -pNA release as a function of nucleophilic
acceptor peptide concentration (NH2-FAASR-NH2). Hydrolysis was
performed with 2.0 mM N-succinyl-A-A-P-F-pNA, in 200 mM tricine
(pH 8.0). Data were fit to a competitive inhibition model.
Figure 7
pH profile of the S195A-catalyzed ligation reaction. The standard
ligation reaction was performed for 16 h, with varying buffer pH.
Buffers used: MES (2-[N-morpholino]ethanesulfonic acid) pH 5.5–6.5;
MOPS (3-[N-morpholino]propanesulfonic acid) pH 6.5–7.5; tricine
pH 7.5–8.5; CHES (2-[N-cyclohexlamino]sulfonic acid) pH 8.0–10.
The maximum ligation rate was set to 1. Trend lines are for the visual
aid of the reader.
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P1 amino acid) was examined (Figure 8). The kinetic con-
stants kcat and kcat/Km are observed to follow the same
trend for the S195A variant as for the wild-type protease,
indicating the retention of primary specificity. Although
the requirement is less stringent, SGPB also shows P1′
specificity toward large hydrophobic amino acid residues.
This observation is reflected in the ligation activity of the
S195A variant, which is capable of ligating acceptor pep-
tides containing an amino-terminal phenylalanine, leucine
or alanine residue (listed in order of preference, data
not shown).
Stability of the S195A ligase variant
The ligation activity of the S195A variant was examined in
various concentrations of urea and GnHCl (Figure 9). Lig-
ation was observed in concentrations of urea as high as
2 M, but the enzyme was inactivated by relatively low
concentrations of GnHCl. 
The S195A-catalyzed ligation was also investigated over a
range of temperatures (Figure 10). Ligation reactions pro-
ceeded at temperatures as high as 55°C, although a dra-
matic decrease in rate occurs above ~42°C, which probably
indicates enzyme denaturation. The thermostability of the
enzyme was evaluated in the absence of substrates. Puri-
fied protein was heated at various temperatures, and then
tested for ligase activity. The enzyme was completely
inactivated in less than 1 minute at 45°C, and less than
20 minutes at 37°C. Wild-type SGPB has a t1/2 of
8.3 minutes at 55°C under similar experimental conditions. 
These results indicate that the S195A variant is less stable
than the wild-type enzyme. Several variants of the wild-
type enzyme with increased thermal stability have been
generated (t1/2 of 34–84 minutes at 55°C) [47], and we are
currently in the process of making the serine to alanine
substitutions in these, in an attempt to create a more
stable ligase.
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Figure 8
Comparison of wild-type and S195A variant substrate specificity.
Shown are relative (a) kcat and (b) kcat/Km values for the SGPB- and
S195A-variant-catalyzed hydrolysis of N-succinyl-AAPX-pNA. For
both wild-type (white bars) and variant (gray bars) enzymes, kcat and
kcat/Km for hydrolysis of N-succinyl-AAPF-pNA were set to 1. For the
hydrolysis of the alanine (*) substrate by S195A, a rate was
observed; however, it was not possible to determine accurate kinetic
constants. The valine (♦) substrate was not hydrolyzed by the
S195A variant.
Figure 9
Relative ligation rates by S195A in urea and guanidine hydrochloride.
Standard ligation reactions were performed for 16 h, with varying
amounts of urea or guanidine hydrochloride. Ligation reactions were
analyzed by HPLC, and the relative ligation rate calculated. The
maximum ligation rate was set to 1. Trend lines are for the visual aid of
the reader.
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Significance
Recent developments in peptide ligation, including the
enzymatic coupling of protein fragments, have allowed
tremendous advances in the study of protein structure
and function. It has become relatively practical to create
proteins with non-natural amino acids incorporated site-
specifically, which can serve as probes of catalytic activ-
ity, binding and structural alterations. 
An enzyme of the chymotrypsin superfamily (Strepto-
myces griseus protease B, SGPB) was made into an effec-
tive coupling catalyst by single amino-acid substitutions
at Ser195. Replacement of the catalytic serine residue
with small hydrophobic amino acids resulted in a novel
class of catalysts that couple peptides via an acyl-imida-
zole intermediate. The mutant enzymes were able to
efficiently ligate peptides activated with thioester, ester
and para-nitroanilide activating groups, and showed
poor amidase activity.
The potential to apply this mutagenic strategy to the pro-
teases contained within the chymotrypsin superfamily
(including variants of SGPB itself) may enable a more
general method for creating peptide ligases, covering a
wide range of specificities and physical characteristics.
An array of coupling enzymes would undoubtedly
expand the application of semi-synthetic strategies in
protein engineering. Furthermore, the ability of such
mutants to use readily accessible and hydrolytically
stable anilide and methyl esters as acyl donors permits
the use of high pH (8–10), as required for deprotonation
of amine nucleophiles. The ability to work at high pH
provides a versatility not achieved by peptide-ligation
strategies involving the use of less hydrolytically stable
thioesters. 
Materials and methods
Bacterial strains
DNA manipulation was performed as previously described [43] in
E. coli strain DH5α. Protein expression was performed in the protease-
deficient strain B. subtilis DB104.
Plasmids
The pNC-B plasmid is a pUC-19 derivative containing the full-length
SGPB gene (sprB) and was used as a template for mutagenic PCR.
The pEB-11 plasmid is an E. coli/B. subtilis shuttle vector, and con-
tains components of pUC-18 for maintenance in E. coli, and compo-
nents of pUB110 for maintenance in B. subtilis [31]. In addition, it
contains the promoter and pre- regions of the subtilisin BPN gene,
allowing expression and secretion of downstream gene products in
B. subtilis. The pEB-B8 plasmid contains the pro-mature region of the
sprB gene (wild-type SGPB) cloned in frame behind the promoter and
pre- regions of subtilisin in pEB-11 [48]. 
Primers 
Primers (Table 2) were synthesized on an Applied Biosystems 392
DNA/RNA synthesizer. Mismatch codons are shown in bold (shown
with the mutant amino acid encoded above) and restriction sites are in
italics (labeled with specific restriction site). 
Construction of the expression vectors
pEB-HDg/-HDa/-HDc
All three vectors were constructed in the same manner. pEB-HDx
(x = a, g or c) contains the promoter region of subtilisin and a gene
construct encoding the pre- region of subtilisin, followed by the
propeptide and mature region of SGPB (with a S195X mutation).
BF1 and S195X (X = Ala, Gly or Cys) were used as primers in a PCR
with pNC-B as template, and the 658 base pair amplified product iso-
lated. The fragment was digested with KpnI and ligated into pUC-19
(digested with KpnI and HincII and treated with CIP (calf intestinal
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Figure 10
Temperature profile of the S195A-catalyzed ligation reaction. Standard
ligation reactions were performed for 16 h at various reaction
temperatures. The maximum ligation rate was set to 1. Trend lines are
for the visual aid of the reader.
Table 2
PCR primers.
BF1: 5′ GGTACCTGCGCAACCCCCCGGACG 3′
KpnI
Gly
S195G: 5′ GAGCGGACCGCCGCCGTCGCC 3′
Rsr II
Ala
S195A: 5′ GAGCGGACCGCCGGCGTCGCC 3′
Rsr II
Cys
S195C: 5′ GAGCGGACCGCCGCAGTCGCC 3′
Rsr II
Asn
H57N: 5′ ACCGCCGGCAACTGCACGGACGGC 3′
pEBloPvuII-: 5′ GGCCTCTTCGCTATTAC 3′
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alkaline phosphatase). Vectors with inserts of the correct size were
identified by restriction analysis and were partially sequenced to verify
accurate amplification, mutagenesis and ligation. 
Plasmids containing the mutagenized inserts were digested with DraIII
and Rsr II, and the 310 base pair fragment gel-purified and ligated into
pEB-B8 (digested with DraIII and Rsr II and treated with CIP). A vector
containing the correct insert was isolated on the basis of restriction
digest analysis and sequenced. 
pEB-nDg
pEB-nDg contains the subtilisin promoter and contains the gene con-
struct encoding the subtilisin pre- region, followed by the propeptide
and mature region of SGPB (with H57N and S195G mutations). 
H57N and pEBloPvuII- (primes downstream of gene construct) were
used in a PCR with pEB-HDg as template. The ~600 base pair ampli-
fied product was gel-purified, digested with Pst I and ligated into
pUC-19 (digested with Pst I and Sma I and treated with CIP). Vectors
containing inserts of the correct size were identified by restriction
analysis and labeled pJE-Bng.
pJE-Bng was digested with NgoMI and Pst I, and the 465 base pair
fragment was gel-purified, and ligated into pEB-HDg (digested with
NgoMI and PstI and treated with CIP). A vector containing the correct
insert was identified by restriction analysis, sequenced to ensure muta-
tion, and designated pEB-nDg.
Production of the SGPB variants
B. subtilis DB104 cultures harboring the respective expression vectors
were grown at 30°C in PEM (32 g tryptone, 2 g yeast extract, 5 g NaCl
per l) + kanamycin (50 mg/l). For large-scale expression of the S195A
and S195G variants, the cultures were scaled up to 15 l and grown at
30°C with 6 l/min airflow at 200 rpm in a Chemap Fermenter. SGPD
was added to a final concentration of 0.35 U/l [30] when the A600 had
reached 0.6, after which the culture was grown for an additional 48 h
and harvested for purification. 
Protein gels and western blots
SDS–PAGE and western blots were performed as previously
described [40,49].
Purification of S195A and S195G variants
Bacteria were removed from the large-scale (15 l) fermenter culture by
filtration with a Millipore Pellicon apparatus equipped with two 0.45 µm
cutoff membrane cassettes. The filtrate (culture supernatant) was
exchanged into 25 mM sodium acetate (pH 4.6) and concentrated to
approximately 1 l with two 10,000 molecular weight cutoff membrane
cassettes. The retentate (concentrated supernatant) was centrifuged at
10,000 × g to remove any material. Purification of the SGPB variants
from the retentates was performed by a combination of ammonium
sulfate precipitation (S195G variant only) and ion-exchange chro-
matography on Source-15Q and Source-15S columns (Pharmacia).
Purified proteins were analyzed by matrix assisted laser desorption/ion-
ization–time-of-flight (MALDI–TOF) mass spectrometry (PerSeptive
Biosystems Voyager-DE), and amino-terminal amino acid sequencing
(Applied Biosystems 473 peptide sequencer). Protein concentration
was determined by the method of Scopes [50].
Peptides
The acceptor pentapeptide, NH2-F-A-A-S-R-NH2 (using single-letter
amino-acid code), was synthesized on an Applied Biosystems 432A
peptide synthesizer or purchased from SynPep Corporation (Dublin, CA). 
Synthesis of N-succinyl-A-A-P-F-OMe
N-succinyl-A-A-P-F-OH was purchased from SynPep. 50 mg of
peptide was dissolved in anhydrous ether and allowed to react with an
excess of diazomethane for 1 h [51]. The peptide methyl ester was
lyophilized, resuspended in 10% methanol and purified by reverse
phase (C-18) HPLC. 
Kinetic studies
Amidase activity was determined using the following assay mixture:
100–2000 µM substrate (N-succinyl-Ala—Ala–Pro–Xaa-p-nitroanilide,
where Xaa is phenylalanine, methionine, leucine, alanine or valine) in
200 mM Tricine buffer (pH 8.0), in a total volume of 1 ml, 25°C. The
release of p-NA was detected spectrophotometrically at 412 nm. 
Ligation reactions
Typically, ligation reactions were composed of 1.2 mM donor peptide
(N-succinyl-A-A-P-F-SBz (Sigma), N-succinyl-A-A-P-F-pNA (BACHEM,
Torrance, CA) or N-succinyl-A-A-P-F-SMe (Gryphon Sciences, San
Francisco) or N-succinyl-A-A-P-F-OMe), 11 mM F-A-A-S-R-NH2
(SynPep), 4% 1,4-butanediol (for methyl ester and thioesters (Sigma)),
50 mM Tricine (N-tris[hydroxymethyl]methylglycine) (pH 8.0) and
~1 µM enzyme, and were performed at 30°C. Deviations from these
conditions are noted in the figure legends. Ligation reactions were ana-
lyzed by reverse-phase HPLC (RP-HPLC) on a Waters LC Module 1
equipped with an analytical Nova-pak C-18 column (8 × 10). Solvent A
was water containing 0.05% TFA; solvent B was acetonitrile containing
0.045% TFA. Gradients were 5% to 65% B over 30 min. Peaks from
HPLC analysis were identified by MALDI–TOF mass spectrometry.
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